Relaxin potentiates ß2-adrenoceptor mediated bronchodilation in precision-cut lung slices (PCLS) from mouse models of airway inflammation and fibrosis, and in human airways
J. Bourke (Clayton, Australia), M. Lam (Clayton, Australia), C. Maksdi (Clayton, Australia), J. Chitty (Clayton, Australia), B. Thomas (Clayton, Australia), P. Bardin (Clayton, Australia), J. Jaffar (Prahran, Australia), G. Westall (Prahran, Australia), S. Royce (Clayton, Australia)
Source: International Congress 2019 – Advances in asthma pharmacology
Session: Advances in asthma pharmacology
Session type: Poster Discussion
Number: 3880
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Bourke (Clayton, Australia), M. Lam (Clayton, Australia), C. Maksdi (Clayton, Australia), J. Chitty (Clayton, Australia), B. Thomas (Clayton, Australia), P. Bardin (Clayton, Australia), J. Jaffar (Prahran, Australia), G. Westall (Prahran, Australia), S. Royce (Clayton, Australia). Relaxin potentiates ß2-adrenoceptor mediated bronchodilation in precision-cut lung slices (PCLS) from mouse models of airway inflammation and fibrosis, and in human airways. 3880
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: